TOP HEALTH INDUSTRY ISSUES OF 2019 - THE NEW HEALTH ECONOMY COMES OF AGE - FIERCEHEALTHCARE WEBINAR JAN. 16, 2019 - MEDSPACE INNOVATIONS

Page created by Darren Rice
 
CONTINUE READING
TOP HEALTH INDUSTRY ISSUES OF 2019 - THE NEW HEALTH ECONOMY COMES OF AGE - FIERCEHEALTHCARE WEBINAR JAN. 16, 2019 - MEDSPACE INNOVATIONS
Top health industry issues of 2019
The New Health Economy comes of age

FierceHealthcare webinar
Jan. 16, 2019
TOP HEALTH INDUSTRY ISSUES OF 2019 - THE NEW HEALTH ECONOMY COMES OF AGE - FIERCEHEALTHCARE WEBINAR JAN. 16, 2019 - MEDSPACE INNOVATIONS
Today’s presenters
Speakers

                   Rob Friz               Kathy Michael        Gurpreet Singh              Karen Young
             US Health Services Tax    US Health Industries   US Health Services      US Pharmaceutical and
                    Leader                 Tax Leader              Leader              Life Sciences Leader
Moderators

                                Sarah Haflett                            Trine Tsouderos
                        Director and Research Leader          Director and Regulatory Center Leader
                          Health Research Institute                 Health Research Institute

                                                                                                              2
TOP HEALTH INDUSTRY ISSUES OF 2019 - THE NEW HEALTH ECONOMY COMES OF AGE - FIERCEHEALTHCARE WEBINAR JAN. 16, 2019 - MEDSPACE INNOVATIONS
About this report
Each December, right before the holidays, HRI names the
trends that will shape the US health industry in the
coming year.

These issues are chosen because they will significantly
impact insurers, healthcare providers, pharmaceutical
and life sciences companies, new entrants, employers
large and small, government entities and, of course,
American consumers.

The report, HRI’s flagship, is developed from input from
dozens of PwC partners and staff, interviews with
healthcare executives and other industry experts and
analysis of government and industry data. This year, Top
health industry issues also included perspectives from
firm platform experts and thought leadership.

The report also is informed by surveys conducted by HRI
of consumers and executives from providers, payers and
pharmaceutical and life sciences companies.

Top health industry issues of 2019: The New Health Economy comes of age
PwC                                                                       3
TOP HEALTH INDUSTRY ISSUES OF 2019 - THE NEW HEALTH ECONOMY COMES OF AGE - FIERCEHEALTHCARE WEBINAR JAN. 16, 2019 - MEDSPACE INNOVATIONS
US healthcare is finally showing signs of behaving like
other industries

The US health industry is looking less like a special case and is beginning to behave like other
industries. So for 2019’s top health industry issues report, HRI for the first time is featuring
business issues common to all industries.

The details may be healthcare, but the business issues are shared with many other parts of the
economy.

Top health industry issues of 2019: The New Health Economy comes of age
PwC                                                                                                4
TOP HEALTH INDUSTRY ISSUES OF 2019 - THE NEW HEALTH ECONOMY COMES OF AGE - FIERCEHEALTHCARE WEBINAR JAN. 16, 2019 - MEDSPACE INNOVATIONS
Consumers are ready to embrace a new era of care
delivery

Top health industry issues of 2019: The New Health Economy comes of age
PwC                                                                       5
TOP HEALTH INDUSTRY ISSUES OF 2019 - THE NEW HEALTH ECONOMY COMES OF AGE - FIERCEHEALTHCARE WEBINAR JAN. 16, 2019 - MEDSPACE INNOVATIONS
Top health industry issues of 2019: The New Health Economy
comes of age
                                                                          Your company’s new, upskilled worker of the
                                                               01         future is you

                                   Creating the Southwest
                                   Airlines of healthcare                 02

                                                                                       Digital therapeutics/connected care
                                                                               03      reshape the life sciences industry

                                      Private equity – acquirer, competitor,
                                      and partner
                                                                                      04

                                                                                             05     The Affordable Care
                                                                                                    Act in 2019: Still alive

                                        Tax reform has only just begun for healthcare
                                        companies
                                                                                                     06
Top health industry issues of 2019: The New Health Economy comes of age
PwC                                                                                                                            6
TOP HEALTH INDUSTRY ISSUES OF 2019 - THE NEW HEALTH ECONOMY COMES OF AGE - FIERCEHEALTHCARE WEBINAR JAN. 16, 2019 - MEDSPACE INNOVATIONS
Your company’s new, upskilled health worker of the future is you

Key Findings & Implications                             Few workers say their employers offer
                                                        training in AI, RPA, or data analytics
Key findings
• Many provider aren’t confident their workforces
  have the skills they need, yet pharma execs are
•   Workers see jobs at risk, but are eager to learn
•   Few healthcare companies are offering training in
    data and analytics, AI, and other emerging tech

Implications                                            03    Implications applicable to all sectors
                                                              of healthcare
•   Modernize the HR strategy
•   Consider how best to train your employees
•   Consider which employees should get top priority

                                                                                                       7
TOP HEALTH INDUSTRY ISSUES OF 2019 - THE NEW HEALTH ECONOMY COMES OF AGE - FIERCEHEALTHCARE WEBINAR JAN. 16, 2019 - MEDSPACE INNOVATIONS
Creating the Southwest Airlines of healthcare

Key Findings & Implications                              Average deductible for employer-
                                                         sponsored plans over the past decade
Key findings
•   Americans are shouldering higher deductibles
    and cost-sharing, and many say they cannot
    afford them
•   The seeds of innovation when it comes to
    developing value lines can be found in
    organizations making money off of Medicaid and
    Medicare
•   Consumers want healthcare organizations to
    consider social determinants of health
                                                         03   Implications applicable to all sectors
                                                              of healthcare

Implications
•   Recognize your consumer segments that need
    value
•   Consider partnerships to deliver lower-cost, high-
    quality care
•   Go beyond the prescription coupon
                                                                                                       8
TOP HEALTH INDUSTRY ISSUES OF 2019 - THE NEW HEALTH ECONOMY COMES OF AGE - FIERCEHEALTHCARE WEBINAR JAN. 16, 2019 - MEDSPACE INNOVATIONS
Digital therapeutics and connected care reshape the life sciences
industry

Key Findings & Implications                                Consumers are interested in FDA-
                                                           approved apps or online tools
Key findings
•   The FDA already has approved some new digital
    therapies, with many others in the pipeline
•   A majority of consumers (more than 50%)
    surveyed by HRI are interested in FDA approved
    digital apps or online tools to treat their medical
    conditions
•   Physicians are talking to patients about these tools
    more and more often                                    03   Implications applicable to all sectors
                                                                of healthcare
Implications
•   Focus on outcomes, not just endpoints
•   Evaluate the impact of digital therapeutics and
    connected care solutions on your practice
•   Explore partnership models focused on
    demonstrating results

                                                                                                         9
TOP HEALTH INDUSTRY ISSUES OF 2019 - THE NEW HEALTH ECONOMY COMES OF AGE - FIERCEHEALTHCARE WEBINAR JAN. 16, 2019 - MEDSPACE INNOVATIONS
Private equity: Healthcare’s new growth accelerator

Key Findings & Implications                               Private equity activity in healthcare has
                                                          steadily increased over the past decade
Key findings
•   Private equity firms are approaching (and
    competing with) corporate entities more frequently
•   Partnerships between private equity and
    healthcare buyers also are evolving beyond
    acquisitions
•   HRI expects to see more co-investing in 2019
Implications                                              03    Implications applicable to all sectors
                                                                of healthcare
•   Realize that the market is ripe for divestitures
•   Partner with private equity to unlock possibilities
    for growth and scale
•   Understand that private equity is accelerating
    change in the industry and eyeing disruptors

                                                                                                         10
The Affordable Care Act in 2019: Still alive

Key Findings & Implications                                   Consumers in Medicaid expansion
Key findings                                                  states were more likely to say the ACA
                                                              helped them
•   The reduction of the individual mandate penalty to
    $0 on Jan. 1 (thanks to the Tax Cuts and Jobs Act of
    2017) likely will have the most impact on the
    industry in 2019
•   Further reform is being pushed onto state
    governments as they try to secure insurance
    markets
•   HRI expects continued focus on drug pricing               03    Implications applicable to all sectors
                                                                    of healthcare
Implications
•   Care delivery must move beyond the office and to a
    broader team
•   Attention to drug prices will increase despite a
    slowdown in rule-making for manufacturers
•   Insurance regulations are falling to states, creating a
    patchwork

                                                                                                             11
Tax reform has only just begun for healthcare companies

Key Findings & Implications                      There are over 18k manufacturing
                                                 facilities registered with the FDA
Key findings
• Most of the tax changes will have a negative
  impact on payers and providers, while PLS
  companies will come out ahead

Implications
• Be prepared to act
                                                 03    Implications applicable to all sectors
                                                       of healthcare
• Use tax savings to position for success
• Figure out what operational changes the new
  tax law will require

                                                                                                12
For more information                                          For more on the business issues
                                                              raised in this report:

                                                              Kelly Barnes
For more on the research:                                                                              For more on marketing:
                                                              Global and US Health Industries Leader
Benjamin Isgur                                                                                         Hindy Shaman
                                                              Rob Friz
Health Research Institute Leader                                                                       National Health Industries Marketing Leader
                                                              US Health Services Tax Leader
benjamin.isgur@pwc.com                                                                                 hindy.shaman@pwc.com
                                                              rob.w.friz@pwc.com
Sarah Haflett                                                                                          Rob Wilson
                                                              Jeff Gitlin
Health Research Institute                                                                              National Health Services Marketing Leader
                                                              US Health Industries Advisory Leader
Research Leader                                                                                        robert.wilson@pwc.com
                                                              jeffrey.gitlin@pwc.com
sarah.e.haflett@pwc.com
                                                                                                       Lesley Bakker
                                                              Kathy Michael
Trine Tsouderos                                                                                        National PLS Marketing Leader
                                                              US Health Industries Tax Leader
Health Research Institute Managing                                                                     lesley.bakker@pwc.com
                                                              kathleen.michael@pwc.com
Editor
trine.k.tsouderos@pwc.com                                                                              Jamie Mumford
                                                              Gurpreet Singh
                                                                                                       National Health Industries Marketing Senior
                                                              US Health Services Leader
                                                                                                       Manager
                                                              gurpreet.singh@pwc.com
                                                                                                       jamie.mumford@pwc.com
                                                              Tim Weld
                                                              US Health Industries Assurance Leader
                                                              timothy.r.weld@pwc.com

                                                              Karen Young
                                                              US Pharmaceutical and Life Sciences
                                                              Leader
                                                              karen.c.young@pwc.com
Top health industry issues of 2019: The New Health Economy comes of age
PwC Health Research Institute                                                                                                                        17
Thank you!

pwc.com/us/healthindustries
pwc.com/hri

To download the full report, please visit: www.pwc.com/us/tophealthissues

This publication has been prepared for general guidance on matters of interest only, and does not
constitute professional advice or a contract for services. You should not act upon the information
contained in this publication without obtaining specific professional advice. No representation or
warranty (express or implied) is given as to the accuracy or completeness of the information
contained in this publication, and, to the extent permitted by law.

PricewaterhouseCoopers LLP, its members, employees and agents do not accept or assume any
liability, responsibility or duty of care for any consequences of you or anyone else acting, or refraining
to act, in reliance on the information contained in this publication or for any decision based on it.

© 2018 PricewaterhouseCoopers LLP, a Delaware limited liability partnership. All rights reserved.
PwC refers to the US member firm, and may sometimes refer to the PwC network. Each member
firm is a separate legal entity. Please see www.pwc.com/structure for further details. This content
is for general information purposes only, and should Not be used as a substitute for consultation with
professional advisors.

                                                                                                             14
You can also read